Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.48
-0.12 (-1.58%)
Mar 3, 2026, 4:00 PM EST - Market closed
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
Research and Development of Cell Therapy Product Candidates | 38.91M | 26.00M | 110.78M | 85.08M |
Research and Development of Cell Therapy Product Candidates Growth | 49.64% | -76.53% | 30.21% | - |
| 38.91M | 26.00M | 110.78M | 85.08M |
| 49.64% | -76.53% | 30.21% | - |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 38.91M | 26.00M | 110.78M | 85.08M |
| 49.64% | -76.53% | 30.21% | - |
| 38.91M | 26.00M | 110.78M | 85.08M |
| 49.64% | -76.53% | 30.21% | - |
Source: S&P Global Market Intelligence.
